Jump to content

Bias Capital

From Wikipedia, the free encyclopedia
Bias Capital
Company typePrivate
IndustryVenture capital
FoundedFebruary 2021; 3 years ago (2021-02)
FounderMaximillian Naza
Headquarters,
ProductsInvestments
Websitehttps://bias.capital/

Bias Capital, LLC (commonly known as Bias Capital) is an American venture capital firm that invests in both early-stage start-ups and established growth companies. In addition to its primary investments, the firm operates an angel syndicate, offering accredited investors and qualified purchasers the opportunity to access and participate in select investment opportunities.[1]

Founded with the aim of addressing biases in the venture capital industry, Bias Capital is committed to building a portfolio that reflects the diversity of society. The firm seeks to foster inclusive growth by supporting startups that contribute to a more equitable and dynamic business landscape.

Bias Capital operates as the venture capital arm of PasciVite.

Notable Investments

[edit]

In July 2023, Bias Capital led a $25 million Series A funding round for Parker Health, a biotech company focused on revolutionizing electronic health records and healthcare management.[2]

Other notable investments include Grabango, Wayflyer, Fintor, Valtivis, Flower CO. and FLYR.[3]

References

[edit]
  1. ^ "Bias Capital". 2021-10-06. Archived from the original on 2021-10-06. Retrieved 2024-12-16.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  2. ^ "Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare". Archived from the original on 2024-10-05. Retrieved 2024-12-13.
  3. ^ "Bias Capital Investment Portfolio | PitchBook". pitchbook.com. Retrieved 2024-12-16.